Dr. Sudhir Bansal, MD (he/him) is an Endocrinologist in Warwick, RI with over 17 years of experience. What is your opinion of Dr. Sudhir Bansal, MD? Rate this provider below so other people can make informed decision.
Over 17 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Sudhir Bansal, MD has received over $69,341 which includes payments from the following companies:
$44,632.79 from AstraZeneca Pharmaceuticals LP
$10,752.19 from AbbVie, Inc.
$4,777.38 from Corcept Therapeutics
$1,787.46 from sanofi-aventis U.S. LLC
$1,312.55 from Merck Sharp & Dohme Corporation
$1,153.27 from Amarin Pharma Inc.
$796.49 from LILLY USA, LLC
$737.29 from Amgen Inc.
$693.40 from Janssen Pharmaceuticals, Inc
$424.24 from Boehringer Ingelheim Pharmaceuticals, Inc.
$381.52 from Novo Nordisk Inc
$356.94 from GlaxoSmithKline, LLC.
$270.65 from Shire North American Group Inc
$232.94 from Regeneron Healthcare Solutions, Inc.
$180.54 from Abbott Laboratories
$131.72 from Pfizer Inc.
$87.79 from Regeneron Pharmaceuticals, Inc.
$76.30 from Takeda Pharmaceuticals America, Inc.
$71.50 from Radius Health, Inc.
$64.05 from Antares Pharma, Inc.
Payments received by Dr. Sudhir Bansal, MD were from the following categories:
$52,200.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!